DNA methylation and gene silencing in cancer
- PMID: 16341240
- DOI: 10.1038/ncponc0354
DNA methylation and gene silencing in cancer
Abstract
Epigenetic changes such as DNA methylation act to regulate gene expression in normal mammalian development. However, promoter hypermethylation also plays a major role in cancer through transcriptional silencing of critical growth regulators such as tumor suppressor genes. Other chromatin modifications, such as histone deacetylation and chromatin-binding proteins, affect local chromatin structure and, in concert with DNA methylation, regulate gene transcription. The DNA methylation inhibitors azacitidine and decitabine can induce functional re-expression of aberrantly silenced genes in cancer, causing growth arrest and apoptosis in tumor cells. These agents, along with inhibitors of histone deacetylation, have shown clinical activity in the treatment of certain hematologic malignancies where gene hypermethylation occurs. This review examines alteration in DNA methylation in cancer, effects on gene expression, and implications for the use of hypomethylating agents in the treatment of cancer.
Similar articles
-
Reactivating the expression of methylation silenced genes in human cancer.Oncogene. 2002 Aug 12;21(35):5496-503. doi: 10.1038/sj.onc.1205602. Oncogene. 2002. PMID: 12154410 Review.
-
Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.Ann Hematol. 2005 Dec;84 Suppl 1:54-60. doi: 10.1007/s00277-005-0006-z. Ann Hematol. 2005. PMID: 16228241
-
Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.Cancer Res. 2002 Nov 15;62(22):6456-61. Cancer Res. 2002. PMID: 12438235
-
Demethylation of DNA by decitabine in cancer chemotherapy.Expert Rev Anticancer Ther. 2004 Aug;4(4):501-10. doi: 10.1586/14737140.4.4.501. Expert Rev Anticancer Ther. 2004. PMID: 15270655 Review.
-
DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.Haematologica. 2002 Dec;87(12):1324-41. Haematologica. 2002. PMID: 12495905 Review.
Cited by
-
The association between dietary vitamin B12 and lung cancer risk: findings from a prospective cohort study.Eur J Cancer Prev. 2021 May 1;30(3):275-281. doi: 10.1097/CEJ.0000000000000660. Eur J Cancer Prev. 2021. PMID: 33656837 Free PMC article.
-
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?Cancers (Basel). 2022 Oct 5;14(19):4865. doi: 10.3390/cancers14194865. Cancers (Basel). 2022. PMID: 36230787 Free PMC article. Review.
-
High-throughput sequencing for biology and medicine.Mol Syst Biol. 2013;9:640. doi: 10.1038/msb.2012.61. Mol Syst Biol. 2013. PMID: 23340846 Free PMC article. Review.
-
Compartmentation of metabolites in regulating epigenome of cancer.Mol Med. 2016 Sep;22:349-360. doi: 10.2119/molmed.2016.00051. Epub 2016 Apr 18. Mol Med. 2016. PMID: 27258652 Free PMC article.
-
Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome.Int J Mol Cell Med. 2016 Spring;5(2):90-9. Epub 2016 Jun 19. Int J Mol Cell Med. 2016. PMID: 27478805 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources